Not applicableUnknownNCT02145286
What this trial is testing
Phase 1/2 Study to Determine Optimal Dose for Treating Bone Metastases Using Novel STAT-RT Workflow
Who this might be right for
Metastatic Bone Lesion
Paul W. Read, MD 47
Showing 20 of 0 results